94 related articles for article (PubMed ID: 3527948)
1. Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody.
Ernst CS; Sears HF; Herlyn M; Herlyn D; Steplewski Z; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S79-86. PubMed ID: 3527948
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Sears H; Iliopoulos D; Lubeck M; Douillard JY; Sindelar W; Tempero M; Mellstedt H; Maher M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S51-8. PubMed ID: 3488951
[TBL] [Abstract][Full Text] [Related]
3. Generation of a monoclonal antibody (G9) reactive with an organ-specific, tumor-associated epitope of human colon carcinoma.
Gold DV; Ishizaki G; Keller P; Lew K
Cancer Res; 1989 Nov; 49(22):6412-8. PubMed ID: 2478283
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF
J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.
Wagener C; Yang YH; Crawford FG; Shively JE
J Immunol; 1983 May; 130(5):2308-15. PubMed ID: 6187849
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma.
Herlyn D; Sears HF; Ernst CS; Iliopoulos D; Steplewski Z; Koprowski H
Am J Clin Oncol; 1991 Oct; 14(5):371-8. PubMed ID: 1951172
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tumor growth inhibition.
Steplewski Z; Herlyn D; Lubeck M; Kimoto Y; Herlyn M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S59-64. PubMed ID: 3744386
[No Abstract] [Full Text] [Related]
8. Binding of murine immunoglobulin to human tissues after immunotherapy with anticolorectal carcinoma monoclonal antibody.
Shen JW; Atkinson B; Koprowski H; Sears HF
Int J Cancer; 1984 Apr; 33(4):465-8. PubMed ID: 6368409
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of CO17-1A monoclonal antibody.
Lobuglio AF; Saleh M; Peterson L; Wheeler R; Carrano R; Huster W; Khazaeli MB
Hybridoma; 1986 Jul; 5 Suppl 1():S117-23. PubMed ID: 3488950
[TBL] [Abstract][Full Text] [Related]
10. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
11. Comparative sequence analysis of CO17-1A antigen-specific monoclonal antibodies.
Caton AJ
Hybridoma; 1986 Jul; 5 Suppl 1():S11-6. PubMed ID: 3744376
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
13. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
Haspel MV; McCabe RP; Pomato N; Janesch NJ; Knowlton JV; Peters LC; Hoover HC; Hanna MG
Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with metastasizing colo-rectal carcinoma with mouse monoclonal antibodies (Moab 17-1A): a progress report.
Frödin JE; Biberfeld P; Christensson B; Philstedt P; Sundelius S; Sylvén M; Wahren B; Koprowski H; Mellstedt H
Hybridoma; 1986 Jul; 5 Suppl 1():S151-61. PubMed ID: 3744379
[TBL] [Abstract][Full Text] [Related]
15. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
16. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
17. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
18. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
[TBL] [Abstract][Full Text] [Related]
19. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
20. Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Scott AM; Geleick D; Rubira M; Clarke K; Nice EC; Smyth FE; Stockert E; Richards EC; Carr FJ; Harris WJ; Armour KL; Rood J; Kypridis A; Kronina V; Murphy R; Lee FT; Liu Z; Kitamura K; Ritter G; Laughton K; Hoffman E; Burgess AW; Old LJ
Cancer Res; 2000 Jun; 60(12):3254-61. PubMed ID: 10866319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
